Court of Justice (Fourth Chamber) 3 July 2019, C-668/17 P (Viridis Pharmaceutical Ltd v European Union Intellectual Property Office.)

JUDGMENT OF THE COURT (Fourth Chamber) 3 July 2019 ( *1 ) (Appeal – EU trade mark – Revocation proceedings – Word mark Boswelan – Genuine use – Absence – Use of the mark in the context of a clinical trial prior to the submission of an application for marketing authorisation for a medicinal product – Proper reason for non-use – Concept) In Case C‑668/17 P, APPEAL under Article 56 of the Statute of